Clinical Trials Logo
  1. Home
  2. Coronary Artery Disease
  3. NCT02593994
  4. Details
NCT02593994 Clinical Trial

IRIS-Onyx Cohort in the IRIS-DES Registry

Coronary Artery Disease Clinical Trial

— IRIS-Onyx  

Official title:
Evaluation of Effectiveness and Safety of Resolute Onyx™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02593994
Other study ID # AMCCV2015-04
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 2015
Est. completion date December 31, 2029

Study information
Verified date December 2023
Source Asan Medical Center
Contact Seung-jung Park, MD, PhD
Email sjpark@amc.seoul.kr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate the relative effectiveness and safety of Onyx stent compared to other (drug eluting stents) DES.

Recruitment information / eligibility
Status Recruiting
Enrollment 4500
Est. completion date December 31, 2029
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - Age 19 and more - Intervention with Onyx Drug Eluting Stent - Agreed with written informed consent form Exclusion Criteria: - Intervention with Onyx drug eluting coronary stent and other drug eluting stent at the same time - Life expectancy of 1year and under - Cardiac shock

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Onyx Drug Eluting Stent group

Locations
Country Name City State
Korea, Republic of Hallym University Sacred Heart Hospital Anyang
Korea, Republic of Soon Chun Hyang University Hospital Bucheon Bucheon
Korea, Republic of Soon Chun Hyang University Hospital Cheonan Cheonan
Korea, Republic of Gangwon National Univ. Hospital Chuncheon
Korea, Republic of Daegu Catholic University Medical Center Daegu
Korea, Republic of Keimyung University Dongsan Medical Center Daegu
Korea, Republic of Chungnam National University Hospital Daejeon
Korea, Republic of The Catholic University of Korea, Daejeon ST. Mary's Hospital Daejeon
Korea, Republic of Gangneung Asan Hospital Gangneung
Korea, Republic of Chonnam National University Hospital Gwangju
Korea, Republic of Inje University Ilsan Paik Hospital Ilsan
Korea, Republic of Gachon University Gil Hospital Incheon
Korea, Republic of Inha University Hospital Incheon
Korea, Republic of Presbyterian Medical Center Jeonju
Korea, Republic of Kwangju Christian Hospital Kwangju
Korea, Republic of Dong-A Medical Center Pusan
Korea, Republic of Inje University Pusan Paik Hospital Pusan
Korea, Republic of Pusan National University Hospital Pusan
Korea, Republic of Bundang CHA Hospital Seongnam
Korea, Republic of Asan Medical Center Seoul Songpa-gu
Korea, Republic of Gangnam Severance Hospital Seoul
Korea, Republic of Hallym University Kangnam Sacred Heart Hospital Seoul
Korea, Republic of Kangbuk Samsung Hospital Seoul
Korea, Republic of Kangdong Sacred Heart Hospital Seoul
Korea, Republic of Korea University Anam Hospital Seoul
Korea, Republic of Korea University Guro Hospital Seoul
Korea, Republic of The Catholic University of Korea Seoul St. Mary's Hospital Seoul
Korea, Republic of The Catholic University of Korea St. Paul's Hospital Seoul
Korea, Republic of The Catholic University of Korea, Yeouido St. Mary's Hospital Seoul Republic Of Korea
Korea, Republic of St.carollo Hospital Suncheon
Korea, Republic of Ulsan University Hospital Ulsan
Korea, Republic of Wonju Severance Christian Hospital Wonju
Korea, Republic of Pusan National University Yangsan Hospital Yangsan

Sponsors (3)
Lead Sponsor Collaborator
Seung-Jung Park CardioVascular Research Foundation, Korea, Medtronic Korea Co., Ltd.

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary Stent thrombosis As per Academic Research Consortium (ARC) standard, definite or probable stent thrombosis 1 year
Secondary All death 5 year
Secondary Cardiac death 5 year
Secondary Myocardial infarction 5 year
Secondary Composite event of death or myocardial infarction 5 year
Secondary Composite event of cardiac death or myocardial infarction 5 year
Secondary Composite event rate death, myocardial infarction, target vessel revascularization 5 year
Secondary Target Vessel revascularization 5 year
Secondary Target Lesion revascularization 5 year
Secondary Stent thrombosis 5 year
Secondary Stroke 5 year
Secondary Procedural success defined as less than 30% residual stenosis at the completion of procedure without death or Q wave myocardial infarction or urgent revascularization participants will be followed for the duration of hospital stay, an expected average of 3days. 3 day
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A